TABLE 1.
Demographic and clinical characteristics of participants (mean ± SD).
| Demographic characteristics | HC (n = 21) | BC (n = 32) | P-values |
| Age (years) | 62.6 ± 4.4 | 61.8 ± 5.2 | 0.63 |
| Education (years) | 11.8 ± 1.7 | 11.8 ± 3.5 | 0.44 |
| Anxiety (STAI-B) | 42.3 ± 9.3 | 40.8 ± 10.5 | 0.60 |
| Depression (BDI) | 4.1 ± 3.2 | 3.6 ± 3.2 | 0.44 |
| Clinical characteristics | HC (n = 21) | BC (n = 32) | |
| Stage of the cancer, n (%): 0 I IIA | NA | 17 (53%) 12 (38%) 3 (9%) | |
| Tumorectomy, n (%) Mastectomy, n (%) | NA | 29 (91%) 4 (13%)* | |
| Time since radiotherapy (months) | NA | 8 ± 2.4 | |
| Treated with endocrine therapy, Not treated with endocrine therapy | NA | 16 (50%) 16 (50%) | |
| Fatigue (FACIT-F) | NA | 36.6 ± 10 | |
| Well-being (FACT-G) | NA | 84.6 ± 17 |
*One patient receiving tumorectomy and mastectomy.
HC, healthy controls; BC, breast cancer; STAI-B, State Trait Anxiety Inventory–Trait; BDI, Beck depression inventory; FACIT-F, Functional Assessment of Chronic Illness Therapy–Fatigue; FACT-G, Functional Assessment of Cancer Therapy–General.
Age, Education, and Depression were compared with Wilcoxon tests and Anxiety with the student’s t.test.